We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00130130
First Posted: August 15, 2005
Last Update Posted: February 1, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center
  Purpose
The overall purpose of this project is to improve nurse skills regarding neuropathic pain (NP) assessment, treatment and referral practices through implementation of an evidence-based algorithm and to improve selected patient outcomes as a result of algorithm use.

Condition Phase
Pain Phase 1 Phase 2

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

Further study details as provided by Dartmouth-Hitchcock Medical Center:

Primary Outcome Measures:
  • To implement an evidence based screening, assessment, treatment, and referral guideline for hematology/oncology patients with NP receiving care [ Time Frame: outcome measures will consist of the NPVAS, and a PPCPS adapted rom the original project. Adequate satisfaction will be defined as 25% or mor of all patients reporting being very or completely satisfied as measured by PPCPS ]

Enrollment: 20
Study Start Date: August 2005
Study Completion Date: December 2011
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Detailed Description:
Neuropathic pain (NP) is defined as pain that arises from injury, disease or dysfunction of the central or peripheral nervous system. For the patient focused phase of the project NP treatment will be guided via the Peripheral Neuropathy Treatment Algorithm. Patients will receive algorithm-specific treatment for 12 weeks.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cancer patients experiencing NP from a variety of causes
Criteria

Inclusion Criteria:

  • Cancer patients experiencing NP from a variety of causes
  • NP Visual Analogue Scale (VAS) score equal to or > 4 with 12 week estimated duration
  • Karnofsky Performance Status (KPS) 60% or greater
  • Age greater than 18

Exclusion Criteria:

  • Patients undergoing anticancer or invasive pain procedures specifically intended to palliate NP are ineligible
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00130130


Locations
United States, New Hampshire
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
Investigators
Principal Investigator: Ellen Lavoie-Smith, ARNP Dartmouth-Hitchcock Medical Center
  More Information

Responsible Party: Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier: NCT00130130     History of Changes
Other Study ID Numbers: D 0403
ONS
First Submitted: August 12, 2005
First Posted: August 15, 2005
Last Update Posted: February 1, 2012
Last Verified: January 2012

Additional relevant MeSH terms:
Neuralgia
Pain
Neurologic Manifestations
Nervous System Diseases
Peripheral Nervous System Diseases
Neuromuscular Diseases
Signs and Symptoms